cycloheximide has been researched along with Bile Duct Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leelawat, K; Leelawat, S; Narong, S; Udomchaiprasertkul, W | 1 |
| Bronk, SF; Gores, GJ; Ustundag, Y | 1 |
2 other study(ies) available for cycloheximide and Bile Duct Cancer
| Article | Year |
|---|---|
Induction of MKP-1 prevents the cytotoxic effects of PI3K inhibition in hilar cholangiocarcinoma cells.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Chromones; Cycloheximide; Dual Specificity Phosphatase 1; Humans; Morpholines; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation | 2010 |
Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells.
Topics: Animals; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Caspases; Cell Line; Cell Line, Tumor; Cholangiocarcinoma; Cycloheximide; Cysteine Proteinase Inhibitors; Endoplasmic Reticulum; Humans; Leupeptins; NF-kappa B; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Synthesis Inhibitors; Rats | 2007 |